Sun Pharmaceuticals Limited has secured the approval of US food and drug administration (USFDA) for its Abbreviated New Drug Application to market the generic drug Topamax, according to statement released by the company.
Topamax is used to treat patients suffering from tonic-clonic seizures and has annual sales of $2.5 billion in the US market.